- Home
- DLHC vs CTOR Comparison
DLHC vs CTOR Comparison
Compare DLHC & CTOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DLHC
- CTOR
- Stock Information
- Founded
- DLHC 1969
- CTOR 2021
- Country
- DLHC United States
- CTOR United States
- Employees
- DLHC N/A
- CTOR N/A
- Industry
- DLHC Business Services
- CTOR
- Sector
- DLHC Consumer Discretionary
- CTOR
- Exchange
- DLHC Nasdaq
- CTOR NYSE
- Market Cap
- DLHC 74.2M
- CTOR 63.7M
- IPO Year
- DLHC N/A
- CTOR N/A
- Fundamental
- Price
- DLHC $5.51
- CTOR $3.10
- Analyst Decision
- DLHC
- CTOR Buy
- Analyst Count
- DLHC 0
- CTOR 2
- Target Price
- DLHC N/A
- CTOR $6.00
- AVG Volume (30 Days)
- DLHC 46.8K
- CTOR 1.8M
- Earning Date
- DLHC 07-30-2025
- CTOR 08-11-2025
- Dividend Yield
- DLHC N/A
- CTOR N/A
- EPS Growth
- DLHC 75.08
- CTOR N/A
- EPS
- DLHC 0.38
- CTOR N/A
- Revenue
- DLHC $377,074,000.00
- CTOR N/A
- Revenue This Year
- DLHC N/A
- CTOR N/A
- Revenue Next Year
- DLHC N/A
- CTOR N/A
- P/E Ratio
- DLHC $14.52
- CTOR N/A
- Revenue Growth
- DLHC N/A
- CTOR N/A
- 52 Week Low
- DLHC $2.72
- CTOR $0.55
- 52 Week High
- DLHC $11.99
- CTOR $49.00
- Technical
- Relative Strength Index (RSI)
- DLHC 63.84
- CTOR N/A
- Support Level
- DLHC $5.32
- CTOR N/A
- Resistance Level
- DLHC $5.66
- CTOR N/A
- Average True Range (ATR)
- DLHC 0.24
- CTOR 0.00
- MACD
- DLHC -0.03
- CTOR 0.00
- Stochastic Oscillator
- DLHC 72.60
- CTOR 0.00
About DLHC DLH Holdings Corp.
DLH Holdings Corp is a provider of technology-enabled business process outsourcing and program management solutions in the United States. The company offers services to several government agencies which include the Department of Veteran Affairs. The company is engaged in public health, performance evaluation, and health operations to solve the complex problems faced by civilian and military customers alike, leveraging digital transformation, artificial intelligence, analytics, cloud-based applications, telehealth systems, and others.
About CTOR CITIUS ONCOLOGY INC
Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.